. Author manuscript; available in PMC: 2017 Mar 1.

Published in final edited form as: Int J Cardiovasc Imaging. 2015 Oct 22;32(3):461–467. doi: 10.1007/s10554-015-0792-x

Table 1.

Baseline characteristics of the study participants.

Parameter	TAVI	AVR	Controls	p-value
n	17	12	9	---
Sex [females/males]	8/9	4/8	1/8	---
Age [years]	77 ± 7	76 ± 4	55 ± 16	0.001
Prosthetic types	Edwards Sapien XT (n = 17),	Porcine: Medtronic Hancock (n = 4), Labcore (n = 1); Bovine: Edwards Perimount (n = 2), Sorin Mitroflow (n = 2), unknown (n = 3)	---	---
Labeled valve size	25.8 ± 2.2	23.2 ± 2.2	---	0.012
Effective orifice area [cm²]	1.9 ± 0.3	1.5 ± 0.5	4.0 ± 0.8	< 0.001
Effective orifice area index [cm²/m²]	0.9 ± 0.3	0.8 ± 0.2	2.0 ± 0.3	< 0.001
LV^* enddiastolic volume [ml]	157.0 ± 63.2	149.9 ± 61.8	139.6 ± 41.4	0.870
LV mass [g\|	175.7 ± 59.3	165.2 ± 55.1	129.2 ± 25.3	0.079
LV stroke volume [ml]	87.9 ± 33.1	84.9 ± 32.3	91.4 ± 28.2	0.796
LV ejection fraction [%]	57.2 ± 10.1	58.0 ± 10.9	65.9 ± 6.1	0.038
Ascending aortic diameter [mm]	34.8 ± 3.1	38.5 ± 4.4	30.7 ± 4.8	0.002

Results are given as mean ± standard deviation or as frequencies. The p-values are tested by the Kruskal-Wallis analysis.

LV, left ventricular